Warren, Ohio-based Insight Hospital and Medical Center Trumbull has paused both inpatient and outpatient services, and has made the decision to furlough an unspecified number of employees amid ongoing financial disruptors from the hospital’s former owner Dallas-based Steward Health Care.…
The Latest
Concord (N.H.) Hospital Health System has named Jesus Delgado as its new chief digital and information officer. Mr. Delgado will oversee the health system’s information technology services division, according to a March 24 news release. Previously, he served as system…
More than a year after its suspension, the heart transplant program at Richmond (Va.) VA Medical Center is under investigation, the Richmond Times-Dispatch reported March 24. A source familiar with the investigation told the Times-Dispatch the probe was opened in…
Raed Khoury, who has been in the healthcare industry for more than 40 years, is leading a multimillion-dollar initiative to address one of its biggest challenges: waste. According to a 2020 study, wasteful medical care costs the U.S. between $600…
Healthcare is dynamic and ever-changing, testing those of us fortunate enough to serve as leaders in ways we often cannot anticipate and through events we cannot always fully control. It is up to us to find a way forward, even…
Bursting budgets and overflowing technology don’t mix. Here’s what 67 respondents would prioritize with their investments. The leaders featured in this article are speaking at Becker’s 10th Annual Health IT + Digital Health + RCM Conference. The conference will take…
Many health systems are embracing AI across various applications, including documentation, the revenue cycle and claims denials. While this technology shows tremendous potential in improving the delivery of healthcare, more work is needed to realize AI’s full potential in clinical…
A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly inherited Alzheimer’s disease. The study, published in The Lancet, involved 73 participants across…
Novo Nordisk and United Laboratories International’s subsidiary, United Biotechnology Co. have entered into a potentially $2 billion license agreement for UBT251, a glucagon triple-receptor agonist in early stage clinical development for obesity, Type 2 diabetes and other diseases. Novo Nordisk…
Since becoming executive vice president and COO of Dover, Del.-based Bayhealth in January, Kyle Benoit found there is a fine line leaders must walk when joining a new organization. “You don’t want to wait too long to start laying out…